Arbutus Biopharma (I9DN) Q2 2024 Earnings Report
DE:I9DN Q2 2024 EPS Results
- Actual EPS
- -EUR 0.10
- Consensus EPS
- -EUR 0.09
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- -EUR 0.09
DE:I9DN Q2 2024 Revenue Results
- Actual Revenue
- EUR 1.55M
- Expected Revenue
- EUR 1.58M
- Beat/Miss
- Missed by -EUR 35.82K
- YoY Revenue Growth
- -62.89%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- Before Open
- Conference Call
- Thursday, August 1, 2024
DE:I9DN Upcoming Earnings
Arbutus Biopharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:I9DN Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:I9DN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -0.02- | -0.04 | ― | ― |
| Aug 12, 2026 | 2026 (Q2) | -0.02-0.03 | 0.01 | -400.00% (-0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.030.78 | -0.12 | 769.23% (+0.90) | |
| Mar 23, 2026 | 2025 (Q4) | -0.03-0.01 | -0.06 | 85.71% (+0.05) | |
| Nov 13, 2025 | 2025 (Q3) | -0.03-0.04 | -0.09 | 60.00% (+0.05) | |
| Aug 06, 2025 | 2025 (Q2) | -0.040.01 | -0.1 | 109.09% (+0.11) | |
| May 14, 2025 | 2025 (Q1) | -0.09-0.12 | -0.09 | -30.00% (-0.03) | |
| Mar 27, 2025 | 2024 (Q4) | -0.07-0.06 | -0.11 | 41.67% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | -0.08-0.09 | -0.11 | 16.67% (+0.02) | |
| Aug 01, 2024 | 2024 (Q2) | -0.09-0.10 | -0.09 | -10.00% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
